🔎 Trials Near Me

Home › Smoking and Youth › NCT07102082

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

RecruitingHealthy volunteers welcome

Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect

Who can join

Ages 21 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
* Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
* Open to trying a non-combusted oral tobacco product.
* Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
* Have the ability to read, write, and communicate in English.
* Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure

Exclusion Criteria:

* Plan to quit smoking in the next 30 days.
* Use of smokeless tobacco at least weekly in the last 6 months.
* Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
* Unwilling or unable to follow protocol requirements.
* Pregnant or planning to become pregnant (by self report)

About the study

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

What is being tested

Sponsor: Roswell Park Cancer Institute · Participants: 160 · Started: Sep 25, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07102082

Locations in the U.S.

New YorkRoswell Park, Buffalo

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.